Targeted Respiratory Drug Delivery by Tribo Charged Sprays

Develop a new technology for precise drug delivery to the lungs using charged droplets to prevent coalescence, enhancing treatment efficacy for conditions like lung cancer and COVID-19.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

The main purpose of this proposal is to develop a radically new technology for very precisely delivering medicine to the human body. Targeted deposition of drug formulations to the lungs exhibits great promise in several treatments, e.g. siRNA treatment against lung cancer or mRNA vaccination against COVID-19.

Current Challenges

This requires oral and nasal inhalation for which spray pumps and nebulizers are widely used to transform an aqueous formulation into a soft mist spray. However, producing the necessary drop size is hampered by droplet coalescence, making drops too large and polydisperse; because of this, they deposit in the wrong places.

Droplet Size and Deposition

  • Large droplets between 10 and 50 micrometers deposit mostly in the upper respiratory tract (mouth, throat, or nasal cavity) through ballistic impact on the mucosal tissue.
  • Small droplets between 5 and 10 micrometers can be lifted by the airstreams and deposit mostly in the lower respiratory tract (bronchi and lungs).

Our Innovation

Our innovation relies on the charging of drops through the friction with the nozzle material. The charged drops repel and do not coalesce, allowing precise control of their size to target e.g. the lungs.

Conclusion

This allows us to achieve safe and effective targeted deposition of drugs and/or vaccines with hitherto unequaled precision.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-1-2024
Einddatum30-6-2025
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • UNIVERSITEIT VAN AMSTERDAMpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Rational and Simulation-Supported Design of Inhalable RNA Nanocarrier

RatInhalRNA aims to design and optimize biocompatible siRNA nanoparticles for pulmonary delivery using a combination of DoE, MD simulations, and ML to enhance gene silencing efficacy.

€ 2.000.000
ERC ADG

Precision Rayleigh jet sprays

This project aims to develop novel spray nozzles that produce perfectly monodisperse sprays by controlling instabilities through advanced hydrodynamics and nanofabrication, enhancing applications in medicine and agriculture.

€ 2.500.000
MIT Haalbaarheid

Onderzoek naar het toedienen van antivirale formuleringen middels spray nozzletechnologie geïntegreerd in een neusspray ter preventie van respiratoire infecties

Het project onderzoekt de technische en economische haalbaarheid van een short fatty acid-neusspray als antivirale bescherming met optimale verneveling en kostprijsanalyse.

€ 20.000
MIT R&D Samenwerking

FIBAIR - Inhalation spray nozzles with improved air mixing for lung fibrosis

Het project ontwikkelt nieuwe mixkamer-technologie voor inhalatoren om de behandeling van longfibrose bij (ex-)COVID-19-patiënten te verbeteren en de levensverwachting te verhogen.

€ 270.891